Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900- ELVITEGRAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [150 + 150 + 200 +10 MG; CÁP/COMP]
Tender Description
ELVITEGRAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [150 + 150 + 200 +10 MG; CÁP/COMP]
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.